ProCan scientists at CMRI are analysing tens of thousands of examples of all types of cancer from all over the world to develop a library of information to advance scientific discovery and enhance clinical treatment worldwide.
This ambitious world-first research program aims to analyse the human cancer proteome on an unprecedented scale. To date, more than 45,000 tumour sample mass spectrometry runs have been completed. Well-annotated cancer samples are being sourced from collaborators and tissue banks worldwide. We are actively seeking collaborators with suitable cancer sample cohorts.
This ambitious world-first research program aims to analyse the human cancer proteome on an unprecedented scale.
Information for potential collaborators can be found here.
Many people and organisations help make ProCan's work possible.
ProCan's scientific publications
There are five ProCan teams working together to to source, prepare, process and analyse cancer samples.
View our latest newsletters and annual reports
Technology and methods developed by ProCan
Dr Peter Hains coordinates all of ProCan's research programs
The ProCan Cancer Data Science Group uses advanced computational methods including machine learning to analyse multi-omic data.
ProCan Laboratory encompasses sample management and processing.
The ProCan Oncology group is responsible for sample acquisition, including liaison with collaborators to assess collaboration opportunities.
ProCan’s Software Engineering team has developed and maintains the IT infrastructure which enables and underpins ProCan’s outcomes.
The ProCan Operations team provides the operational and project management skills and processes to track and coordinate all activities.
